Cystic Fibrosis [clinicaltrials_resource:7dc6de64103854ac6f29e37f8745969b]
Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders [clinicaltrials:NCT00001223]Role of Genetic Factors in the Development of Lung Disease [clinicaltrials:NCT00001532]Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis [clinicaltrials:NCT00004287]Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients [clinicaltrials:NCT00004296]Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease [clinicaltrials:NCT00004315]Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis [clinicaltrials:NCT00004428]Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis [clinicaltrials:NCT00004440]Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis [clinicaltrials:NCT00004441]Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer [clinicaltrials:NCT00004471]Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis [clinicaltrials:NCT00004489]Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis [clinicaltrials:NCT00004533]Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis [clinicaltrials:NCT00004705]Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis [clinicaltrials:NCT00004747]Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis [clinicaltrials:NCT00004779]Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis [clinicaltrials:NCT00004806]Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis [clinicaltrials:NCT00004829]A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis [clinicaltrials:NCT00005110]Growth Hormone Use in Cystic Fibrosis - a Multicenter Study [clinicaltrials:NCT00005112]Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis [clinicaltrials:NCT00006063]Behavioral Treatment of Weight Gain in CF [clinicaltrials:NCT00006169]Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis [clinicaltrials:NCT00006273]A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis [clinicaltrials:NCT00006280]Bone Health of People With Cystic Fibrosis [clinicaltrials:NCT00008762]Pressure Support Ventilation During CF Exacerbations [clinicaltrials:NCT00008775]Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis [clinicaltrials:NCT00014768]Study of Hepatic Glucose Production and De Novo Lipogenesis in Patients With Cystic Fibrosis [clinicaltrials:NCT00014781]Benefits and Risks of Newborn Screening for Cystic Fibrosis [clinicaltrials:NCT00014950]Tissue Collection From People With Cystic Fibrosis [clinicaltrials:NCT00015756]Phase II Study of Growth Hormone in Children With Cystic Fibrosis [clinicaltrials:NCT00016445]Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis) [clinicaltrials:NCT00016744]Study of Mycobacterial Infections [clinicaltrials:NCT00018044]Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging [clinicaltrials:NCT00023465]Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa [clinicaltrials:NCT00027183]A Study in Adult and Pediatric Patients With Cystic Fibrosis [clinicaltrials:NCT00034515]Gene Modifiers of Cystic Fibrosis Lung Disease [clinicaltrials:NCT00037765]Genetic Modifiers of Cystic Fibrosis: Sibling Study [clinicaltrials:NCT00037778]Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis [clinicaltrials:NCT00043316]Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis [clinicaltrials:NCT00043342]Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease [clinicaltrials:NCT00056147]Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric Patients [clinicaltrials:NCT00060801]
condition [clinicaltrials_vocabulary:condition]
Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders [clinicaltrials:NCT00001223]Role of Genetic Factors in the Development of Lung Disease [clinicaltrials:NCT00001532]Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis [clinicaltrials:NCT00004287]Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients [clinicaltrials:NCT00004296]Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease [clinicaltrials:NCT00004315]Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis [clinicaltrials:NCT00004428]Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis [clinicaltrials:NCT00004440]Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis [clinicaltrials:NCT00004441]Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer [clinicaltrials:NCT00004471]Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis [clinicaltrials:NCT00004489]Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis [clinicaltrials:NCT00004533]Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis [clinicaltrials:NCT00004705]Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis [clinicaltrials:NCT00004747]Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis [clinicaltrials:NCT00004779]Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis [clinicaltrials:NCT00004806]Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis [clinicaltrials:NCT00004829]A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis [clinicaltrials:NCT00005110]Growth Hormone Use in Cystic Fibrosis - a Multicenter Study [clinicaltrials:NCT00005112]Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis [clinicaltrials:NCT00006063]Behavioral Treatment of Weight Gain in CF [clinicaltrials:NCT00006169]Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis [clinicaltrials:NCT00006273]A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis [clinicaltrials:NCT00006280]Bone Health of People With Cystic Fibrosis [clinicaltrials:NCT00008762]Pressure Support Ventilation During CF Exacerbations [clinicaltrials:NCT00008775]Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis [clinicaltrials:NCT00014768]Study of Hepatic Glucose Production and De Novo Lipogenesis in Patients With Cystic Fibrosis [clinicaltrials:NCT00014781]Benefits and Risks of Newborn Screening for Cystic Fibrosis [clinicaltrials:NCT00014950]Tissue Collection From People With Cystic Fibrosis [clinicaltrials:NCT00015756]Phase II Study of Growth Hormone in Children With Cystic Fibrosis [clinicaltrials:NCT00016445]Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis) [clinicaltrials:NCT00016744]Study of Mycobacterial Infections [clinicaltrials:NCT00018044]Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging [clinicaltrials:NCT00023465]Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa [clinicaltrials:NCT00027183]A Study in Adult and Pediatric Patients With Cystic Fibrosis [clinicaltrials:NCT00034515]Gene Modifiers of Cystic Fibrosis Lung Disease [clinicaltrials:NCT00037765]Genetic Modifiers of Cystic Fibrosis: Sibling Study [clinicaltrials:NCT00037778]The Role of Bacteria and Genetic Variations in Cystic Fibrosis [clinicaltrials:NCT00043225]Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis [clinicaltrials:NCT00043316]Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis [clinicaltrials:NCT00043342]Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease [clinicaltrials:NCT00056147]
condition browse [clinicaltrials_vocabulary:condition-browse]
Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders [clinicaltrials:NCT00001223]Role of Genetic Factors in the Development of Lung Disease [clinicaltrials:NCT00001532]Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis [clinicaltrials:NCT00004287]Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients [clinicaltrials:NCT00004296]Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease [clinicaltrials:NCT00004315]Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis [clinicaltrials:NCT00004428]Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis [clinicaltrials:NCT00004440]Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis [clinicaltrials:NCT00004441]Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer [clinicaltrials:NCT00004471]Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis [clinicaltrials:NCT00004489]Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis [clinicaltrials:NCT00004533]Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis [clinicaltrials:NCT00004705]Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis [clinicaltrials:NCT00004747]Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis [clinicaltrials:NCT00004779]Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis [clinicaltrials:NCT00004806]Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis [clinicaltrials:NCT00004829]A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis [clinicaltrials:NCT00005110]Growth Hormone Use in Cystic Fibrosis - a Multicenter Study [clinicaltrials:NCT00005112]Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis [clinicaltrials:NCT00006063]Behavioral Treatment of Weight Gain in CF [clinicaltrials:NCT00006169]Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis [clinicaltrials:NCT00006273]A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis [clinicaltrials:NCT00006280]Bone Health of People With Cystic Fibrosis [clinicaltrials:NCT00008762]Pressure Support Ventilation During CF Exacerbations [clinicaltrials:NCT00008775]Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis [clinicaltrials:NCT00014768]Study of Hepatic Glucose Production and De Novo Lipogenesis in Patients With Cystic Fibrosis [clinicaltrials:NCT00014781]Benefits and Risks of Newborn Screening for Cystic Fibrosis [clinicaltrials:NCT00014950]Tissue Collection From People With Cystic Fibrosis [clinicaltrials:NCT00015756]Phase II Study of Growth Hormone in Children With Cystic Fibrosis [clinicaltrials:NCT00016445]Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis) [clinicaltrials:NCT00016744]Study of Mycobacterial Infections [clinicaltrials:NCT00018044]Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging [clinicaltrials:NCT00023465]Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa [clinicaltrials:NCT00027183]A Study in Adult and Pediatric Patients With Cystic Fibrosis [clinicaltrials:NCT00034515]Gene Modifiers of Cystic Fibrosis Lung Disease [clinicaltrials:NCT00037765]Genetic Modifiers of Cystic Fibrosis: Sibling Study [clinicaltrials:NCT00037778]The Role of Bacteria and Genetic Variations in Cystic Fibrosis [clinicaltrials:NCT00043225]Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis [clinicaltrials:NCT00043316]Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis [clinicaltrials:NCT00043342]Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease [clinicaltrials:NCT00056147]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
eligibility for clinicaltrials:NCT01112059 [clinicaltrials_resource:24f3b78069d1a50a0b6b0bde1a21ebab]eligibility for clinicaltrials:NCT00255242 [clinicaltrials_resource:3b093a51c4445c174f7fc02653384e69]eligibility for clinicaltrials:NCT01429259 [clinicaltrials_resource:7cf781a880b6438b786c90d0e3ddac07]eligibility for clinicaltrials:NCT02286050 [clinicaltrials_resource:8f96b785a4fa366c16403e1ca3e76184]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT01112059 [clinicaltrials_resource:24f3b78069d1a50a0b6b0bde1a21ebab]eligibility for clinicaltrials:NCT00590005 [clinicaltrials_resource:313b8c20eb3b82ac6ccab4d3450dbcd4]eligibility for clinicaltrials:NCT00255242 [clinicaltrials_resource:3b093a51c4445c174f7fc02653384e69]eligibility for clinicaltrials:NCT01429259 [clinicaltrials_resource:7cf781a880b6438b786c90d0e3ddac07]eligibility for clinicaltrials:NCT02286050 [clinicaltrials_resource:8f96b785a4fa366c16403e1ca3e76184]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Cystic Fibrosis [clinicaltrials_resource:7dc6de64103854ac6f29e37f8745969b]
Bio2RDF identifier
7dc6de64103854ac6f29e37f8745969b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7dc6de64103854ac6f29e37f8745969b
identifier
clinicaltrials_resource:7dc6de64103854ac6f29e37f8745969b
title
Cystic Fibrosis
@en
type
label
Cystic Fibrosis [clinicaltrials_resource:7dc6de64103854ac6f29e37f8745969b]
@en
Cystic Fibrosis